...to about 15% of the health-care conglomerate's top-line. Remicade's marketed in the U.S. by J&J and overseas by Schering-Plough Corp. (SGP), which Merck & Co. (MRK) plans to acquire. J&J reported it earned about $1 billion from the drug's sales for the first...
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Schering Plough Corp News
Wockhardt snapped up in animal health M&A trend
...SA (NYSE:SNY) could buy it and that Eli Lilly and Co. (NYSE:LLY), Novartis AG (NYSE:NVS) and Bayer AG could buy Schering-Plough Corp.'s animal health biz, Intervet. (NYSE:SGP) . And then there's Merial Ltd., the 50-50 animal health JV between Merck & Co. (NYSE:MRK)...
Clear
Clear